首页> 外文期刊>Archives of surgery. >Predicting the risk of perioperative mortality in patients undergoing pancreaticoduodenectomy: a novel scoring system.
【24h】

Predicting the risk of perioperative mortality in patients undergoing pancreaticoduodenectomy: a novel scoring system.

机译:预测接受胰十二指肠切除术的患者围手术期死亡的风险:一种新颖的评分系统。

获取原文
获取原文并翻译 | 示例
       

摘要

OBJECTIVE: To develop and validate a risk score to predict the 30- and 90-day mortality after a pancreaticoduodenectomy or total pancreatectomy on the basis of preoperative risk factors in a high-volume program. DESIGN: Data from a prospectively maintained institutional database were collected. In a random subset of 70% of patients (training cohort), multivariate logistic regression was used to develop a simple integer score, which was then validated in the remaining 30% of patients (validation cohort). Discrimination and calibration of the score were evaluated using area under the receiver operating characteristic curve and Hosmer-Lemeshow test, respectively. SETTING: Tertiary referral center. PATIENTS: The study comprised 1976 patients in a prospectively maintained institutional database who underwent pancreaticoduodenectomy or total pancreatectomy between 1998 and 2009. MAIN OUTCOME MEASURES: The 30- and 90-day mortality. RESULTS: In the training cohort, age, male sex, preoperative serum albumin level, tumor size, total pancreatectomy, and a high Charlson index predicted 90-day mortality (area under the curve, 0.78; 95% CI, 0.71-0.85), whereas all these factors except Charlson index also predicted 30-day mortality (0.79; 0.68-0.89). On validation, the predicted and observed risks were not significantly different for 30-day (1.4% vs 1.0%; P = .62) and 90-day (3.8% vs 3.4%; P = .87) mortality. Both scores maintained good discrimination (for 30-day mortality, area under the curve, 0.74; 95% CI, 0.54-0.95; and for 90-day mortality, 0.73; 0.62-0.84). CONCLUSIONS: The risk scores accurately predicted 30- and 90-day mortality after pancreatectomy. They may help identify and counsel high-risk patients, support and calculate net benefits of therapeutic decisions, and control for selection bias in observational studies as propensity scores.
机译:目的:根据大剂量术前危险因素,制定和验证风险评分,以预测胰十二指肠切除术或全胰切除术后30天和90天的死亡率。设计:从一个前瞻性维护的机构数据库中收集数据。在70%的患者的随机子集中(训练队列),使用多因素logistic回归建立简单的整数评分,然后在其余30%的患者中进行验证(验证队列)。分别使用接收器工作特性曲线和Hosmer-Lemeshow测试下的面积评估得分的辨别和校准。地点:第三级转诊中心。病人:该研究在前瞻性维护的机构数据库中对1976例患者进行了研究,这些患者在1998年至2009年间接受了胰十二指肠切除术或全胰切除术。主要观察指标:30天和90天死亡率。结果:在训练队列中,年龄,男性,术前血清白蛋白水平,肿瘤大小,全胰腺切除术和高Charlson指数可预测90天死亡率(曲线下面积为0.78; 95%CI为0.71-0.85),而除Charlson指数以外的所有这些因素也预测了30天的死亡率(0.79; 0.68-0.89)。验证后,对于30天(1.4%vs 1.0%; P = 0.62)和90天(3.8%vs 3.4%; P = 0.87)死亡率,预测和观察到的风险无显着差异。两项评分均保持良好的区分度(30天死亡率,曲线下面积为0.74; 95%CI为0.54-0.95; 90天死亡率为0.73; 0.62-0.84)。结论:风险评分可准确预测胰腺切除术后30天和90天的死亡率。他们可以帮助识别和建议高危患者,支持和计算治疗决策的净收益,并控制观察性研究中倾向性得分的选择偏见。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号